Form 8-K · Current report

Corteva 8-K, filed Aug 14, 2026

Filed
CIK
0001755672
Accession no.
0001193125-26-352659
AI-generated summary

Summary

Vylor, Inc., a subsidiary of Corteva, filed a first amendment to its Form 10 registration statement with the SEC on August 14, 2026, covering its business, strategy and historical financial results ahead of Corteva's previously announced separation of its seed business into an independent public company. Corteva cautioned that the spin-off's objectives, structure, timing and completion are not assured.

Key points

  • The amended Form 10 provides detailed information on Vylor's business, strategy and historical financial results.
  • Corteva's seed business is intended to become an independent, public company through the separation.
  • Corteva said the spin-off may not be consummated and cited risks including costs, management distraction and potential litigation.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 7.01Regulation FD Disclosure

From the filing

Item 7.01 Regulation FD Disclosure On August 14, 2026, Vylor, Inc., a subsidiary of Corteva, Inc. (“Corteva” or the “Company”) filed its first amendment to its Form 10 registration statement (“Form 10”) with the U.S. Securities and Exchange Commission in connection with Corteva’s previously announced separation of the seed business into an independent, public company. The filing provides detailed information on Vylor’s business, strategy and historical financial results. The Form 10 registration statement is available at www.sec.gov under “Vylor Inc.” and on Corteva’s investor relations website, investors.corteva.com under “Financial Information”. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Corteva in Readster

Add Corteva to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.